These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 8101930)

  • 1. Cross immunity among types of Borrelia burgdorferi.
    Wienecke R; Neubert U; Volkenandt M
    Lancet; 1993 Aug; 342(8868):435. PubMed ID: 8101930
    [No Abstract]   [Full Text] [Related]  

  • 2. Cutaneous manifestations of Lyme borreliosis.
    Berger BW
    Rheum Dis Clin North Am; 1989 Nov; 15(4):627-34. PubMed ID: 2685922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current perspective on Lyme borreliosis.
    Kaslow RA
    JAMA; 1992 Mar; 267(10):1381-3. PubMed ID: 1740862
    [No Abstract]   [Full Text] [Related]  

  • 4. [Therapy indications in positive Borrelia titer].
    Graninger W
    Internist (Berl); 1999 Feb; 40(2):216. PubMed ID: 10097982
    [No Abstract]   [Full Text] [Related]  

  • 5. Prevalence of Erythema migrans Borreliosis in blood donors.
    Schmidt R; Gollmer E; Zunser R; Krüger J; Ackermann R
    Infusionstherapie; 1989 Dec; 16(6):248-51. PubMed ID: 2625363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lyme disease in clinical practice.
    Płusa T; Ligezińska B; Zabielski S; Raczka A
    Pneumonol Alergol Pol; 1992; 60 Suppl 1():71-5. PubMed ID: 1292852
    [No Abstract]   [Full Text] [Related]  

  • 7. Antibodies to Borrelia burgdorferi in patients with carpal tunnel syndrome.
    Kindstrand E
    Acta Neurol Scand; 1992 Jul; 86(1):73-5. PubMed ID: 1519478
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lymphoproliferative responses to Borrelia burgdorferi in patients with erythema migrans, acrodermatitis chronica atrophicans, lymphadenosis benigna cutis, and morphea.
    Buechner SA; Lautenschlager S; Itin P; Bircher A; Erb P
    Arch Dermatol; 1995 Jun; 131(6):673-7. PubMed ID: 7778918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complications of Lyme borreliosis.
    Cooke WD; Dattwyler RJ
    Annu Rev Med; 1992; 43():93-103. PubMed ID: 1580609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lyme disease. A general survey.
    Trevisan G; Cinco M
    Int J Dermatol; 1990; 29(1):1-8. PubMed ID: 2133980
    [No Abstract]   [Full Text] [Related]  

  • 11. [Skin manifestations of Lyme borreliosis].
    Nammous AH; Zubacki D; Dobrzycki I
    Przegl Lek; 2006; 63(4):227-30. PubMed ID: 17080746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Lyme borreliosis with erythema chronicum migrans and Garin-Bujadoux-Bannwarth meningopolyneuritis].
    Berthold F; Trzopek HG; Steudtemann D; Schwesinger G
    Z Gesamte Inn Med; 1989 Nov; 44(21):658-60. PubMed ID: 2609703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isolation of Borrelia burgdorferi in British Columbia.
    Banerjee SN
    Can Commun Dis Rep; 1993 Dec; 19(24):204-5. PubMed ID: 8148784
    [No Abstract]   [Full Text] [Related]  

  • 14. [A case from practice (306). Erythema (chronicum) migrans (stage I of Lyme borreliosis].
    Tschudi M
    Schweiz Rundsch Med Prax; 1994 Sep; 83(39):1091-2. PubMed ID: 7939077
    [No Abstract]   [Full Text] [Related]  

  • 15. [Recurrent erythema and fever].
    Querol JM; Gómez A; Piera P
    Enferm Infecc Microbiol Clin; 1992 Feb; 10(2):117-8. PubMed ID: 1643133
    [No Abstract]   [Full Text] [Related]  

  • 16. [Comparison of test with antigen VlsE (C6) with tests with recombinant antigens in patients with Lyme borreliosis].
    Zajkowska JM; Kondrusik M; Pancewicz SA; Grygorczuk S; Jamiołkowski J; Stalewska J
    Pol Merkur Lekarski; 2007 Aug; 23(134):95-9. PubMed ID: 18044336
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sustained cellular immune responses to Borrelia burgdorferi: lack of correlation with clinical presentation and serology.
    Horowitz HW; Pavia CS; Bittker S; Forseter G; Cooper D; Nadelman RB; Byrne D; Johnson RC; Wormser GP
    Clin Diagn Lab Immunol; 1994 Jul; 1(4):373-8. PubMed ID: 8556471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Erythema migrans and serodiagnosis by enzyme immunoassay and immunoblot with three borrelia species.
    Stanek G; Breier F; Menzinger G; Schaar B; Hafner M; Partsch H
    Wien Klin Wochenschr; 1999 Dec; 111(22-23):951-6. PubMed ID: 10666807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rabbit model of Lyme borreliosis: erythema migrans, infection-derived immunity, and identification of Borrelia burgdorferi proteins associated with virulence and protective immunity.
    Foley DM; Gayek RJ; Skare JT; Wagar EA; Champion CI; Blanco DR; Lovett MA; Miller JN
    J Clin Invest; 1995 Aug; 96(2):965-75. PubMed ID: 7635989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. European interlaboratory comparison of Lyme borreliosis serology.
    Guy EC; Robertson JN; Cimmino M; Gern L; Moosmann Y; Rijpkema SG; Sambri V; Stanek G
    Zentralbl Bakteriol; 1998 Mar; 287(3):241-7. PubMed ID: 9563198
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.